PANCREATIC CANCER NEWS
The latest pancreatic cancer news
- BSD Medical Reports Initiation of a Phase III Pancreatic Cancer Study
BSD Medical Corporation reports initiation of a randomized, multicenter, Phase III clinical study using the BSD-2000 Hyperthermia System to deliver hyperthermia in combination with chemotherapy for the treatment of pancreatic cancer patients.
Read more...
- Threshold Drug Delays Pancreatic Cancer
Threshold reports positive results from a mid-stage study of its pancreatic cancer drug TH-302. Click to view a price quote on THLD . Click to research the Drugs industry.
Read more...
- Fresh hope in pancreatic cancer war
Pancreatic cancer cells can be destroyed by combining two drugs, researchers have found - giving hope that more effective treatments can be developed to combat the disease.
Read more...
- European study of pancreatic cancer to use Utah equipment
European study of pancreatic cancer to use Utah equipment By Steven Oberbeck The Salt Lake Tribune Published Feb 21, 2012 10:55AM MDT Utah’s BSD Medical said a new clinical study is being launched in Europe to further measure the benefits of combining the use of hyperthermia with chemotherapy for the treatment of pancreatic cancer. The study, which will be carried out at four sites in Germany ...
Read more...
- Drug Combo Kills Pancreatic Cancer Cells
Combining gemcitabine with MRK003, an experimental drug, triggers a chain of events leading to pancreatic cancer cell death, researchers from Cambridge reported in the Journal of Experimental Medicine. The researchers explained that when the two drugs are combined, the effect of each one is multiplied, thus intensifying the destruction of pancreatic cancer cells...
Read more...
- Combination of gemcitabine and MRK003 kills pancreatic cancer cells
Cancer Research UK scientists have revealed how a combination of two very different drugs - currently being tested in clinical trials - amplifies the destruction of pancreatic cancer cells, according to research published in the Journal of Experimental Medicine, today.
Read more...